HCV-indeterminate blood donors or occult HCV infection?

HCV-indeterminate blood donors or occult HCV infection?

Dades bibliogràfiques
Autors principals:	Quiroga, J, Carreño, V
Format:	Journal article
Idioma:	English
Publicat:	2005

Ítems similars

HCV-indeterminate blood donors or occult HCV infection? Reply
per: Semmo, N, et al.
Publicat: (2005)

HCV-specific T-CELL responses of acutely HCV infected individuals with and without HIV.
per: Danta, M, et al.
Publicat: (2005)

The seroprevalence of hepatitis C virus (HCV) among 559,890 first-time volunteer blood donors in China reflects regional heterogeneity in HCV prevalence and changes in blood donor recruitment models.
per: Fu, Y, et al.
Publicat: (2010)

Comprehensive analysis of the HCV-specific CD8+T cell response in individuals with chronic or resolved HCV infection.
per: Lauer, G, et al.
Publicat: (2001)

Biodynamics of HCV infection in haemodialysis patients in Pahang
per: Mustafa Mahmoud, Mohammed Imad Al-Deen, et al.
Publicat: (2011)

An HCV vaccine on the fly
per: Laidlaw, S, et al.
Publicat: (2019)

CTL epitope escape and reversion in acute HCV infection.
per: Timm, J, et al.
Publicat: (2004)

Immune control and failure in HCV infection--tipping the balance.
per: Dustin, L, et al.
Publicat: (2014)

Innate and adaptive immune responses in chronic HCV infection
per: Dustin, L
Publicat: (2015)

Optimising T cell vaccination strategies for the prevention of HCV infection
per: Hartnell, F
Publicat: (2018)

T-cell responses during early therapy for HCV infection.
per: Lauer, G, et al.
Publicat: (2003)

New trends of HCV infection in China revealed by genetic analysis of viral sequences determined from first-time volunteer blood donors.
per: Fu, Y, et al.
Publicat: (2011)

Chronic HCV Infection Affects the NK Cell Phenotype in the Blood More than in the Liver
per: Cosgrove, Cormac, et al.
Publicat: (2014)

Glucosidase inhibitors induce HCV glycoproteins misfolding, impair viral assembly and release, and reduce the infectivity of residually secreted HCV particles
per: Chapel, C, et al.
Publicat: (2006)

CD8 epitope escape and reversion in acute HCV infection.
per: Timm, J, et al.
Publicat: (2004)

Superspreading and transmission variation in HCV epidemics
per: Magiorkinis, G, et al.
Publicat: (2012)

Perivenular fibrosis in chronic HCV hepatitis.
per: Kennedy, M, et al.
Publicat: (1999)

Perivenular fibrosis in chronic HCV hepatitis.
per: Kennedy, M, et al.
Publicat: (1998)

Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution
per: Kasprowicz, V, et al.
Publicat: (2011)

Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution.
per: Kasprowicz, V, et al.
Publicat: (2010)

The global distribution and prevalence of HCV genotypes
per: Messina, J, et al.
Publicat: (2014)

HCV immunology--death and the maiden T cell.
per: Willberg, C, et al.
Publicat: (2003)

Analysis of HCV in South East Asia
per: Barnes, E, et al.
Publicat: (2007)

VIROLOGICAL RESPONSES TO COMBINATION THERAPY IN PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1B ARE RELATED WITH DYNAMIC OF HCV-NS-SPECIFIC T CELL RESPONSES
per: Zhang, Y, et al.
Publicat: (2010)

Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy.
per: Rohrbach, J, et al.
Publicat: (2010)

Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection.
per: Fabris, P, et al.
Publicat: (2008)

The molecular epidemiology of HCV and related viruses in Africa
per: Iles, J, et al.
Publicat: (2014)

Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection.
per: Grabowska, A, et al.
Publicat: (2001)

T-cell responses and previous exposure to hepatitis C virus in indeterminate blood donors.
per: Semmo, N, et al.
Publicat: (2005)

PREDICTING CLEARANCE OF ACUTE HCV IN HIV-POSITIVE PATIENTS
per: Thomson, E, et al.
Publicat: (2009)

Therapeutic vaccines in HBV: lessons from HCV
per: Barnes, E
Publicat: (2015)

Ever closer to a prophylactic vaccine for HCV.
per: Swadling, L, et al.
Publicat: (2013)

Alpha-glucosidase inhibitors prevent the assembly and induce a reduction of HCV infectivity
per: Chapel, C, et al.
Publicat: (2006)

The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes
per: von Delft, A, et al.
Publicat: (2017)

Primary, post-primary and non-specific immunoglobulin M responses in HCV infection
per: Dustin, LB, et al.
Publicat: (2012)

Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.
per: Dustin, L, et al.
Publicat: (2012)

Incidence and outcome of hepatitis C infection in blood product recipients: Experience of the Oxford blood centre within the National HCV Lookback Program.
per: Christie, J, et al.
Publicat: (1997)

High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome
per: Kasprowicz, V, et al.
Publicat: (2011)

High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.
per: Kasprowicz, V, et al.
Publicat: (2008)

Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1.
per: Stegmann, K, et al.
Publicat: (2012)